Ceo
Toronto, Ontario
SQI Diagnostics is a life science systems company that has developed an innovative and proprietary microarray based blood testing technology. The technology enables customer to test for multiple antibodies and or biomarkers on an automated platform and provides results faster and cheaper than current technologies. Target customers include the drug discovery pipeline for pharmaceutical drug development.• As CEO of SQI Diagnostics, created shareholder value from bankrupt entity, successfully raised $50 million from Canadian public equity markets, obtained world first FDA regulatory cleared platform technology in our test segment and launched commercial customers;• As an operating executive, excel at managing chaotic turnaround situations, identifying the commercially viable product, mobilizing the team and realizing shareholder value;• As a CEO, able to build effective external stakeholder and institutional shareholder relationships to establish and manage investor confidence;• Multiple public/private/not for profit board experiences; (i) publicly listed biotech company (TSX:V; SQD); (ii) privately held consumer products company (Siamons International), and; (iii) not for profit (Georgian College Foundation Chair);